Carlos A Barrero

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Breast Cancer Risk

Capillary Electrophoresis

Induced Apoptosis

Top Venues

Journal of clinical medicine

Antioxidants (Basel, Switzerland)

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nader Afifi, Carlos A Barrero
Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment. Journal of clinical medicine 12 (4) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Nader Afifi, Carlos A Barrero
Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment. Journal of clinical medicine 12 (4) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Mario C Rico, Oscar Perez-Leal, Mary F Barbe, Mamta Amin, Dennis J Colussi, Magda L Florez, Victor Olusajo, Dennise S Rios, Carlos A Barrero
Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage. Biomolecules 13 (9) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
Nader Afifi, Carlos A Barrero
Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment. Journal of clinical medicine 12 (4) (2023)
Harutyun Khachatryan, Bartlomiej Olszowy, Carlos A Barrero, John Gordon, Oscar Perez-Leal
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1. Biomolecules 13 (2) (2023)
James Li, Sandra Arest, Bartlomiej Olszowy, John Gordon, Carlos A Barrero, Oscar Perez-Leal
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel, Switzerland) 12 (7) (2023)
Connor Quinn, Mario C Rico, Carmen Merali, Carlos A Barrero, Oscar Perez-Leal, Victoria Mischley, John Karanicolas, Scott L Friedman, Salim Merali
Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying TGFβ signaling in hepatic stellate cells. Science translational medicine 15 (715) (2023)
Xu-Qiao Chen, Carlos A Barrero, Rodrigo Vasquez-Del Carpio, E Premkumar Reddy, Chiara Fecchio, Salim Merali, Alessia Deglincerti, Cheng Fang, Jack Rogers, Maria L Maccecchini
Posiphen Reduces the Levels of Huntingtin Protein through Translation Suppression. Pharmaceutics 13 (12) (2021)